New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
08:53 EDTWAG, CVS, ESRXCVS says on track to deliver significant cost savings from streamlining efforts
Says expects to hit full run rate of annual savings of $225M-$275M beginning in 2014. Says working with CMS to resolve Medicare Part D sanction; says SilverScript members not affected by this action. In 2013, says expects to retain at least 60% of the scripts gained during the Walgreens (WAG)/Express Scripts (ESRX) impasse. Says will continue to take a "measured approach" to international growth plan. Comments made on the Q4 earnings conference call.
News For CVS;WAG;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 1, 2015
08:46 EDTCVSCVS Health sees FY15 revenue growth of 7%-8.25%
Subscribe for More Information
08:42 EDTCVSCVS Health says 2016 selling season 'off to a good start'
Updating on the 2015 selling season, CVS reported gross wins of $7.5B and net wins of $4.1B, both up about $500M from its last earnings update. The increases were driven primarily by growth in membership within some health plan clients as well as some additional wins. Regarding the 2016 season, CVS said it has completed about a third of client renewals, which is typical this time of year. CVS added that it remains "well-positioned to provide differentiated products and services that generate savings" for clients, which is "resonating strongly in the market." Comments from the company's earnings call and associated slides.
07:04 EDTCVSCVS Health opened 38 new retail drugstores and closed 10 retail drugstores
Subscribe for More Information
07:03 EDTCVSCVS Health reports Q1 Pharmacy Services revenue up 18.2% to $23.9B
Subscribe for More Information
07:02 EDTCVSCVS Health sees Q1 adjusted EPS $1.17-$1.20, consensus $1.25
Subscribe for More Information
07:02 EDTCVSCVS Health narrows FY15 adjusted EPS to $5.08-$5.19 from $5.05-$5.19
FY15 EPS consensus of $5.16. Backs FY15 free cash flow of $5.9B-$6.2B. Backs FY15 cash flow from operations $7.6B-$7.9B.
07:01 EDTCVSCVS Health reports Q1 adjusted EPS $1.14, consensus $1.08
Subscribe for More Information
April 30, 2015
15:01 EDTCVSNotable companies reporting before tomorrow's open
Subscribe for More Information
14:27 EDTCVS, ESRXOmnicare attracts interest from CVS Health, Express Scripts, Bloomberg says
Omnicare (OCR) is attracting interest from Express Scripts (ESRX), and CVS (CVS), with other potential buyers including Walgreens Boots Alliance (WBA) and McKesson (MKC), Bloomberg reports, citing people with knowledge of the matter. Initial bids are due in May. Reference Link
14:12 EDTCVS, ESRXOmnicare said to attract interest from CVS Health Express Scripts
Subscribe for More Information
05:25 EDTESRXExpress Scripts announces 55.1M share ASR
Express Scripts announced that it has entered into an accelerated share repurchase, or ASR, agreement with Morgan Stanley. Under the terms of the ASR agreement the company will receive an aggregate initial delivery of approximately 55.1M shares of the company's common stock in exchange for a prepayment of $5.5B. The final number of shares to be repurchased will be based on the average of the daily volume-weighted average prices of the company's common stock during the term of the transaction, less a discount and subject to adjustments pursuant to the terms and conditions of the ASR agreement. The final settlement of the transaction under the ASR agreement is expected to occur by the end of 2Q16 but may be accelerated at the option of Morgan Stanley to a date as early as 1Q16.
April 29, 2015
09:16 EDTCVSCVS announces new clinical affiliations with Louisiana, Mississippi organization
Subscribe for More Information
07:12 EDTCVSCVS Health volatility elevated into Q1 and outlook
Subscribe for More Information
April 28, 2015
19:10 EDTESRXOn The Fly: After Hours Movers
Subscribe for More Information
16:03 EDTESRXExpress Scripts sees Q2 adjusted EPS $1.39-$1.43, consensus $1.37
Subscribe for More Information
16:03 EDTESRXExpress Scripts sees 2015 adjusted EPS $5.37-$5.47 vs. previous $5.35-$5.49
Consensus $5.43. It said, "The Company narrowed its adjusted earnings per diluted share guidance from a range of $5.35 to $5.49 to a range of $5.37 to $5.47, which maintains the mid-point of $5.42. The new guidance range represents growth of 10% to 12% over 2014."
16:02 EDTESRXExpress Scripts reports Q1 adjusted EPS $1.10, conensus $1.10
Subscribe for More Information
15:06 EDTESRXNotable companies reporting after market close
Subscribe for More Information
April 23, 2015
13:16 EDTCVS, ESRXPharmacies, PBMs seen as potential buyers after Omnicare said to explore sale
Subscribe for More Information
12:08 EDTESRX, CVSLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Larsen, along with Mary Ptacek, VP of Pharmaceutical Strategies Group and Ruth Krystopolski, EVP of Sanford Health, discuss the 2016-2017 Pharmacy Benefit Managers selling season and which PBMs are poised to gain share, the impact of WBAs growth plans, recent M&A activity and biosimilars on an Analyst/Industry conference call to be held on April 24 at 2 pm.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use